Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
August 24, 2021 at 04:24 am
Share
Teyi Pharmaceutical Group Co.,Ltd announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 358.235 million compared to CNY 300.100 million a year ago. Operating income was CNY 83.067 million compared to CNY 38.369 million a year ago. Net income was CNY 75.314 million compared to CNY 27.390 million a year ago. Basic earnings per share from continuing operations was CNY 0.37 compared to CNY 0.13 a year ago.
TEYI PHARMACEUTICAL GROUP CO., LTD, formerly Guangdong Taicheng Pharmaceutical Co., Ltd., is principally engaged in the production and sale of pharmaceuticals. The Company primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The Company's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.
TEYI PHARMACEUTICAL GROUP CO.,LTD 
